SHZ:300529

Jafron Biomedical Co.,Ltd. · SHZ · Healthcare · CNY · FY for 2025

Figures on this page computed 2026-11-08 13:47 UTC

Last close

n/aCNY

Market data

29.8xP/E
Price / Earnings per Share (diluted)
Source
computed
Taken on
2026-11-08
Reported in
CNY
- computed
- Computed from the filing for 2025
25.5%ROIC
NOPAT / Invested Capital x 100, where NOPAT = Operating Income x (1 - Tax Rate) and Invested Capital = Equity + Total Debt - Cash
Source
computed
Taken on
2026-11-08
Reported in
CNY
- Computed from the filing for 2025
- Computed from the filing for 2025
- Computed from the filing for 2025
- Computed from the filing for 2025
- Computed from the filing for 2025
- Computed from the filing for 2025
26.5%Net margin
Net Income / Revenue x 100
Source
computed
Taken on
2026-11-08
Reported in
CNY
- Computed from the filing for 2025
- Computed from the filing for 2025
27.3%FCF margin
Free Cash Flow / Revenue x 100
Source
computed
Taken on
2026-11-08
Reported in
CNY
- Computed from the filing for 2025
- Computed from the filing for 2025
0.35Debt/equity
Total Debt / Shareholders' Equity
Source
computed
Taken on
2026-11-08
Reported in
CNY
- Computed from the filing for 2025
- Computed from the filing for 2025
n/aDividend yield
We do not hold this figure for this company, so there is nothing to place.
Source
computed
Taken on
2026-11-08
Reported in
CNY
- computed

What it pays out is the furthest below its sector's middle: 0.15 against 0.54 on the market's range.

Follow one yuan

lens 1 of 9

After what it costs to make

78.1%

After running the business

34.3%

After interest and tax

26.5%

After what it must reinvest

27.3%

Kept after the dividend

-4.7%

after what it costs to make, 78.1% of sales; after running the business, 34.3% of sales; after interest and tax, 26.5% of sales; after what it must reinvest, 27.3% of sales; kept after the dividend, -4.7% of sales

The five stops

5 of 5 read

After what it costs to make1,571,418,16778.1%
After running the business690,786,47634.3%
After interest and tax532,821,31426.5%
After what it must reinvest548,625,61727.3%
Kept after the dividend-94,943,333-4.7%

Of every unit of sales, -0.05 is still there after the dividend.

Every figure in this lens

Except where said otherwise: Computed from the filing for 2025

Sales2,011,817,979
Source
computed
Statement
income
Fiscal year
2025
Reported in
CNY
After what it costs to make1,571,418,167
Source
computed
Statement
income
Fiscal year
2025
Reported in
CNY
After running the business690,786,476
Source
computed
Statement
income
Fiscal year
2025
Reported in
CNY
After interest and tax532,821,314
Source
computed
Statement
income
Fiscal year
2025
Reported in
CNY
After what it must reinvest548,625,617
Source
computed
Statement
income
Fiscal year
2025
Reported in
CNY
Kept after the dividend-94,943,333
Source
computed
Statement
income
Fiscal year
2025
Reported in
CNY